Cilfa Opposition, Insulin Analogues / Derivatives, (Ar095114 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, Insulin LysB3 Glu B29, (AR096376A2)
Countries: Argentina Date: 2016
-
CILFA opposition, rosuvastatin, (P000100408)
Countries: Argentina Date: 2002
-
CILFA opposition, benzoilguanidinas (Markush), (P990106043)
Countries: Argentina Date: 2003
-
CILFA opposition, semaglutide, (AR114353A1)
Countries: Argentina Date: 2021
-
CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)
Countries: Argentina Date: 2019
-
CILFA opposition, trelagliptin, (AR109064A2)
Countries: Argentina Date: 2019
-
CILFA opposition, LIXISENATIDE, (AR103415A1)
Countries: Argentina Date: 2017
-
CILFA opposition, semaglutide, (AR112480A1)
Countries: Argentina Date: 2020
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)
Countries: Argentina Date: 2016
-
CILFA opposition, MELOXICAM, (AR100293A2)
Countries: Argentina Date: 2016